Samit M. Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samit M. Shah has a total of 248 co-authors. Here are the top co-authors by number of shared publications:
- Natalija Odanovic
Institute for Cardiovascular Diseases "Dedinje", Belgrade, Serbia
7 shared publications - Steven Pfau
Section of Cardiovascular Medicine, Yale School of Medicine, West Haven, USA
6 shared publications - Alexandra J. Lansky
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA
5 shared publications - Steffne Kunnirickal
Division of Interventional Cardiology The Valley Hospital Ridgewood NJ
5 shared publications - Timothy D. Henry
The Christ Hospital Health System, The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH
5 shared publications Yuhei Kobayashi
New York‐Presbyterian Brooklyn Methodist Hospital Weill Cornell Medical College New York New York USA
5 shared publications
Latest Publications
- 1 November 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (5) , H1485-H1494
Hemodynamic phenotyping in ME/CFS and ANOCA: complementary insights from coronary function testing and invasive cardiopulmonary exercise testing
This study demonstrates a clinically significant association between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and angina with nonobstructive coronary arteries (ANOCA), with 18% of patients with coronary function testing-confirmed ANOCA meeting diagnostic criteria for ME/CFS. Invasive cardiopulmonary exercise testing (iCPET) in patients with concurrent ME/CFS and ANOCA reveals a primary peripheral, not cardiac, limitation to exercise. These findings highlight the complementary roles of coronary function testing and iCPET for hemodynamic phenotyping in this underrecognized patient population.
- 1 November 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (5) , H1485-H1494
Hemodynamic phenotyping in ME/CFS and ANOCA: complementary insights from coronary function testing and invasive cardiopulmonary exercise testing
This study demonstrates a clinically significant association between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and angina with nonobstructive coronary arteries (ANOCA), with 18% of patients with coronary function testing-confirmed ANOCA meeting diagnostic criteria for ME/CFS. Invasive cardiopulmonary exercise testing (iCPET) in patients with concurrent ME/CFS and ANOCA reveals a primary peripheral, not cardiac, limitation to exercise. These findings highlight the complementary roles of coronary function testing and iCPET for hemodynamic phenotyping in this underrecognized patient population.
- 18 October 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Additive Value of Acetylcholine Testing in ANOCA: A US‐Based Multicenter FlowLab Study
Background: Angina with non‐obstructive coronary arteries (ANOCA) is an underrecognized cause of angina with non‐universal diagnostic techniques and patient management strategies. Among ANOCA testing, vasospasm provocation is not always performed mainly due to differences in institutional availability. Aims: Using the FlowLab Study, we quantified vasospasm prevalence among patients with ANOCA at US centers and compared physician decision‐making, endotype distribution, and management between sites that did and did not include vasospasm testing in their workup. Methods: The FlowLab Study was a prospective, multicenter, US‐based study of patients who were referred for coronary angiography and underwent ANOCA testing using the bolus thermodilution method. Presumed diagnosis before cardiac catheterization and final diagnosis after ANOCA testing were compared between participating sites with or without acetylcholine testing availability. Results: A total of 253 procedures at 14 US sites were included in this study. There were 155 procedures among sites performing spasm provocation testing and 98 procedures among sites not performing spasm provocation testing. Prior to cardiac catheterization, sites with spasm provocation testing were less likely to suspect epicardial coronary artery disease as the cause of angina compared to sites without (27% vs. 59.2%, p < 0.0001). A diagnosis of CMD was made more frequently at sites performing spasm testing compared to sites not performing spasm testing (68% vs. 29.6%, p < 0.0001). Similarly, among 125 patients who underwent spasm provocation testing, diagnostic yield increased from 34.4% with bolus thermodilution alone to 84.8% after the addition of spasm provocation testing ( p < 0.001). In these patients, intensification involving calcium channel blockers was more frequent with epicardial (67%) and microvascular spasm (41%) than without spasm (24%, p = 0.001). Conclusions: In contemporary US practice, adding spasm provocation testing to bolus thermodilution more than doubled diagnostic yield and was followed by medication changes directed toward the diagnosed endotype. Differences between sites with and without spasm testing also reflected variation in procedural practice.
- 18 October 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Additive Value of Acetylcholine Testing in ANOCA: A US‐Based Multicenter FlowLab Study
Background: Angina with non‐obstructive coronary arteries (ANOCA) is an underrecognized cause of angina with non‐universal diagnostic techniques and patient management strategies. Among ANOCA testing, vasospasm provocation is not always performed mainly due to differences in institutional availability. Aims: Using the FlowLab Study, we quantified vasospasm prevalence among patients with ANOCA at US centers and compared physician decision‐making, endotype distribution, and management between sites that did and did not include vasospasm testing in their workup. Methods: The FlowLab Study was a prospective, multicenter, US‐based study of patients who were referred for coronary angiography and underwent ANOCA testing using the bolus thermodilution method. Presumed diagnosis before cardiac catheterization and final diagnosis after ANOCA testing were compared between participating sites with or without acetylcholine testing availability. Results: A total of 253 procedures at 14 US sites were included in this study. There were 155 procedures among sites performing spasm provocation testing and 98 procedures among sites not performing spasm provocation testing. Prior to cardiac catheterization, sites with spasm provocation testing were less likely to suspect epicardial coronary artery disease as the cause of angina compared to sites without (27% vs. 59.2%, p < 0.0001). A diagnosis of CMD was made more frequently at sites performing spasm testing compared to sites not performing spasm testing (68% vs. 29.6%, p < 0.0001). Similarly, among 125 patients who underwent spasm provocation testing, diagnostic yield increased from 34.4% with bolus thermodilution alone to 84.8% after the addition of spasm provocation testing ( p < 0.001). In these patients, intensification involving calcium channel blockers was more frequent with epicardial (67%) and microvascular spasm (41%) than without spasm (24%, p = 0.001). Conclusions: In contemporary US practice, adding spasm provocation testing to bolus thermodilution more than doubled diagnostic yield and was followed by medication changes directed toward the diagnosed endotype. Differences between sites with and without spasm testing also reflected variation in procedural practice.
- Open Access
- 14 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 269
“Vox Populi” Fractional Flow Reserve (vpFFR)—Leveraging Wisdom of the Crowd for the Assessment of Hemodynamic Severity of Intermediate Coronary Lesions
Background/Objectives: Diagnostic performance of angiography-derived physiological measures has been benchmarked against two-dimensional (2D) and three-dimensional (3D) quantitative coronary angiography (QCA), which are known for their poor correlation with hemodynamic lesion severity. Relying on the statistical concept of the wisdom of the crowd, we devised a human-performance reference for FFR surrogates, called vox populi FFR (vpFFR), and examined the comparative diagnostic performance of vpFFR, as well as 2D- and 3D-QCA, using invasively measured FFR as the gold standard. Methods: Analyses were performed in a single-center, prospective registry of consecutive FFR procedures. We calculated vpFFR as a mean of five independent, blinded predictions of the invasively measured FFR. Pearson’s correlation coefficient and receiver operating characteristic (ROC) curve analyses were used for diagnostic performance comparisons. Results: In 116 patients (156 vessels), Pearson’s correlation coefficients for vpFFR, 2D-, and 3D-QCA with invasively measured FFR are 0.56, −0.26, and −0.01, respectively (p < 0.001, p = 0.001 and p = 0.918). vpFFR has a sensitivity of 56%, specificity of 84%, positive predictive value of 67%, and negative predictive value of 76%. It correctly classified hemodynamic severity of lesions in 73% of vessels compared to 65% and 51% for 2D- and 3D-QCA, respectively. vpFFR has a larger area under the ROC curve than 2D- and 3D-QCA for predicting positive FFR (0.78, 0.63, and 0.45, respectively, p < 0.001). Conclusions: vpFFR, a mean value of five predictions of invasively measured FFR, has moderate diagnostic performance, superior to 2D- and 3D-QCA using FFR as the gold standard, and can be used as a human-performance reference for existing and emerging angiography-derived physiological measures.
- 14 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 269
Open Access“Vox Populi” Fractional Flow Reserve (vpFFR)—Leveraging Wisdom of the Crowd for the Assessment of Hemodynamic Severity of Intermediate Coronary Lesions
Background/Objectives: Diagnostic performance of angiography-derived physiological measures has been benchmarked against two-dimensional (2D) and three-dimensional (3D) quantitative coronary angiography (QCA), which are known for their poor correlation with hemodynamic lesion severity. Relying on the statistical concept of the wisdom of the crowd, we devised a human-performance reference for FFR surrogates, called vox populi FFR (vpFFR), and examined the comparative diagnostic performance of vpFFR, as well as 2D- and 3D-QCA, using invasively measured FFR as the gold standard. Methods: Analyses were performed in a single-center, prospective registry of consecutive FFR procedures. We calculated vpFFR as a mean of five independent, blinded predictions of the invasively measured FFR. Pearson’s correlation coefficient and receiver operating characteristic (ROC) curve analyses were used for diagnostic performance comparisons. Results: In 116 patients (156 vessels), Pearson’s correlation coefficients for vpFFR, 2D-, and 3D-QCA with invasively measured FFR are 0.56, −0.26, and −0.01, respectively (p < 0.001, p = 0.001 and p = 0.918). vpFFR has a sensitivity of 56%, specificity of 84%, positive predictive value of 67%, and negative predictive value of 76%. It correctly classified hemodynamic severity of lesions in 73% of vessels compared to 65% and 51% for 2D- and 3D-QCA, respectively. vpFFR has a larger area under the ROC curve than 2D- and 3D-QCA for predicting positive FFR (0.78, 0.63, and 0.45, respectively, p < 0.001). Conclusions: vpFFR, a mean value of five predictions of invasively measured FFR, has moderate diagnostic performance, superior to 2D- and 3D-QCA using FFR as the gold standard, and can be used as a human-performance reference for existing and emerging angiography-derived physiological measures.
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (1) , H116-H123
Association between blood pressure and invasive hemodynamic measures in myocardial bridging
Higher procedural blood pressure (BP) is associated with less significant hemodynamic measures in myocardial bridging, suggesting BP should be considered when interpreting borderline hemodynamic measurements.
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (1) , H116-H123
Association between blood pressure and invasive hemodynamic measures in myocardial bridging
Higher procedural blood pressure (BP) is associated with less significant hemodynamic measures in myocardial bridging, suggesting BP should be considered when interpreting borderline hemodynamic measurements.
- Open Access
- 27 September 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (11) , 102179
Multicenter Prospective Assessment of Coronary Microvascular Dysfunction
- 27 September 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (11) , 102179
Open AccessMulticenter Prospective Assessment of Coronary Microvascular Dysfunction
- Open Access
- 29 August 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (11) , 103989
Impact of Age and Sex on Coronary Flow Reserve and Microvascular Function in Patients With Angina and Nonobstructive Coronary Arteries
- 29 August 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (11) , 103989
Open AccessImpact of Age and Sex on Coronary Flow Reserve and Microvascular Function in Patients With Angina and Nonobstructive Coronary Arteries
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e037951
Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy
Background: Serotonin–norepinephrine reuptake inhibitors (SNRIs) inhibit the presynaptic reuptake of serotonin and norepinephrine and are widely used in the treatment of depression and neuropathic pain. We evaluate the impact of SNRIs use on the clinical outcomes of patients presenting with Takotsubo cardiomyopathy (TCM). Methods: We analyzed data from the TriNetX research network. Patients aged ≥18 years with a principal diagnosis of TCM were identified from January 1, 2003, to December 31, 2023. After excluding patients on SSRIs, stimulants, 5‐fluorouracil, capecitabine, gemcitabine, and trastuzumab, patients with myocarditis, pheochromocytoma, acute myocardial infarction, cocaine‐related disorders, and opioid‐related disorders, were also excluded. The final study population was divided into 2 cohorts: patients on SNRIs and patients not on SNRIs. Propensity score matching was used to adjust for potential confounders. The primary outcome was all‐cause mortality, and the secondary outcome was Takotsubo cardiomyopathy‐related complications. Results: A total of 16 853 patients with a diagnosis of TCM were identified, of which 2482 (14.7%) were on SNRIs. The SNRIs cohort were older (mean age 64.1 versus 63.4 years, P =0.012). After propensity score matching, patients on SNRI had lower 7‐day mortality (odds ratio [OR], 0.59 [95% CI, 0.41–0.84], P =0.004), cardiac arrest (OR, 0.58 [95% CI, 0.40–0.84], P =0.004), and ventricular fibrillation (OR, 0.496 [95% CI, 0.248–0.995], P =0.044). At 1 year, patients on SNRI had lower mortality (OR, 0.80 [95% CI, 0.67–0.96], P =0.015). Conclusions: The use of SNRIs among patients presenting with TCM is associated with lower mortality and lower TCM‐related complications.
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e037951
Open AccessSerotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy
Background: Serotonin–norepinephrine reuptake inhibitors (SNRIs) inhibit the presynaptic reuptake of serotonin and norepinephrine and are widely used in the treatment of depression and neuropathic pain. We evaluate the impact of SNRIs use on the clinical outcomes of patients presenting with Takotsubo cardiomyopathy (TCM). Methods: We analyzed data from the TriNetX research network. Patients aged ≥18 years with a principal diagnosis of TCM were identified from January 1, 2003, to December 31, 2023. After excluding patients on SSRIs, stimulants, 5‐fluorouracil, capecitabine, gemcitabine, and trastuzumab, patients with myocarditis, pheochromocytoma, acute myocardial infarction, cocaine‐related disorders, and opioid‐related disorders, were also excluded. The final study population was divided into 2 cohorts: patients on SNRIs and patients not on SNRIs. Propensity score matching was used to adjust for potential confounders. The primary outcome was all‐cause mortality, and the secondary outcome was Takotsubo cardiomyopathy‐related complications. Results: A total of 16 853 patients with a diagnosis of TCM were identified, of which 2482 (14.7%) were on SNRIs. The SNRIs cohort were older (mean age 64.1 versus 63.4 years, P =0.012). After propensity score matching, patients on SNRI had lower 7‐day mortality (odds ratio [OR], 0.59 [95% CI, 0.41–0.84], P =0.004), cardiac arrest (OR, 0.58 [95% CI, 0.40–0.84], P =0.004), and ventricular fibrillation (OR, 0.496 [95% CI, 0.248–0.995], P =0.044). At 1 year, patients on SNRI had lower mortality (OR, 0.80 [95% CI, 0.67–0.96], P =0.015). Conclusions: The use of SNRIs among patients presenting with TCM is associated with lower mortality and lower TCM‐related complications.
- 1 July 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 18 (7) , e012372
Bridging the Gap: Improving Awareness of ANOCA for Patients and Providers
- 1 July 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 18 (7) , e012372
Bridging the Gap: Improving Awareness of ANOCA for Patients and Providers
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (7) , e038843
The Quantitative Flow Ratio Uncertainty‐Zone: Finding Certainty Within Uncertainty
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (7) , e038843
Open AccessThe Quantitative Flow Ratio Uncertainty‐Zone: Finding Certainty Within Uncertainty